CHICAGO (AFP) — The risk of suicidal behavior in children and teenagers using some of the most popular antidepressants is negligible and US authorities should consider removing mandatory health warnings from the drug packaging, according to a study released Tuesday.
The use of many newer antidepressants in the treatment of children and adolescents has been dogged by controversy for years now, with critics and several studies contending that the drugs actually triggered suicidal impulses and attempts in some vulnerable patients.
In 2004, the US Food and Drug Administration (FDA) mandated tough "black box" warnings alerting consumers to the potential deadly side effects of the drugs in younger patients.
in NewsBlack Women White Men,... (Related) Naked boys vs. naked... (Related) The gangs behind bars... (Related) How do I look?... (Related)
in NewsEbony (Related) Advocate, The (Related) Milwaukee Journal... (Related) Independent, The (London) (Related)
And in 2006, the FDA published a review of 24 studies involving 4,400 children and adolescents that showed the drugs carried a twofold increased risk of suicidal behavior, although no suicides were reported.
The furor caused some doctors to shy away ...
No comments:
Post a Comment